Rapid Micro Biosystems, Inc.
RPID
$1.88
-$0.11-5.53%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -29.07% | 43.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -29.07% | 43.94% | |||
| Cost of Revenue | -34.27% | 62.56% | |||
| Gross Profit | 213.11% | -147.13% | |||
| SG&A Expenses | 25.41% | 1.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.98% | 22.30% | |||
| Operating Income | -13.44% | -7.38% | |||
| Income Before Tax | -14.29% | -8.58% | |||
| Income Tax Expenses | -42.86% | 75.00% | |||
| Earnings from Continuing Operations | -14.23% | -8.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.23% | -8.62% | |||
| EBIT | -13.44% | -7.38% | |||
| EBITDA | -13.12% | -8.93% | |||
| EPS Basic | -12.17% | -9.46% | |||
| Normalized Basic EPS | -12.24% | -9.45% | |||
| EPS Diluted | -12.17% | -9.46% | |||
| Normalized Diluted EPS | -12.24% | -9.45% | |||
| Average Basic Shares Outstanding | 1.83% | -0.75% | |||
| Average Diluted Shares Outstanding | 1.83% | -0.75% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||